XERIS PHARMACEUTICALS INC
(98422L107)
Funds Reporting Holdings of XERIS PHARMACEUTICALS INC according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
Redmile Group LLC | 3,000,641 | $34,327k | Jun 30, 2019 | Aug 14, 2019 | |
Deerfield Management Company LP Series C | 2,379,901 | $27,226k | Jun 30, 2019 | Aug 14, 2019 |